Embattled device maker Allergan (NYSE:AGN) hopes it can keep unwelcome buyer Valeant Pharmaceuticals from getting its hands on the company’s advancing R&D pipeline.
Optical/Ophthalmic
Press Release: Abbott receives CE Mark for Tecnis Symfony extended range of vision intraocular lens for cataract patients
Abbott tallies E.U. win for next-gen intraocular lenses
PowerVision raises $30M for FluidVision implantable lens
Ophthalmic devices maker PowerVision finally put a ribbon on its $30 million Series D funding round, planning on using the funds to advance clinical trials in support of regulatory approvals in Europe and the U.S.
Docs announce lab-made ‘mini retina’
Johns Hopkins researchers reported what may be a major breakthrough in vision-saving medicine, creating a functioning "mini retina" made out of human stem cells.
UPDATE: AcuFocus’s Kamra Inlay wins a narrow nod from FDA panel
FDA experts issue mixed vote on Kamra vision-improving implant
A panel of FDA experts today was divided on whether the federal watchdog agency should approve the AcuFocus Kamra Inlay, a 1st-of-a-kind permanent corneal implant for the improvement of near and intermediate vision in patients with presbyopia, a form of age-related far-sightedness.
Brian Walsh looks to transcend glaucoma treatment with CyPass micro-stent
Until recently, the treatment for glaucoma – a group of diseases that cause pressure within the eyeball – consisted of several options, none of them ideal. Patients could opt for medicines, either oral or via eyedrops, to lower eye pressure. A surgical option that in essence creates a drain in the eyeball for ocular fluid is also available, as is a procedure call laser trabeculoplasty that also creates a drainage pathway.
China fines J&J and other contact lens makers for anti-trust violations
Chinese regulators slapped a string of contact lens and eyeglass makers with more than $3 million (19 million yuan) in fines after accusing them of violating the country’s anti-trust laws.
Ora aims to be your one-stop ophthalmology shop
There’s a special sauce in the recipe Ora Inc. uses to run clinical trials for ophthalmology devices and drugs that can reduce the time needed for a study from 6 months to 2 days: The eye care practice started by Ora founder Dr. Mark Abelson.
An ophthalmologist and optometric scientist and fellow at the Mass. Eye & Ear Infirmary, Abelson founded Andover Eye in 1978, his son Stuart Abelson – now Andover, Mass.-based Ora’s CEO – told MassDevice.com.
Staar Surgical hires consumer marketing expert to move Visian lenses
Staar Surgical (NSDQ:STAA) is looking to take its direct-to-consumer marketing to the next level, hiring commercial branding expert David Choromanski to boost the public profile of the Visian ICL implantable lenses.